Shares of Wockhardt traded 3.54 per cent down in trade at 10:53AM on Tuesday.

At present, Khorakiwala himself is engaged in negotiations with a clutch of PE funds.

Net profit was Rs 92.45 crore in July-September a year ago, Wockhardt said in a BSE filing.

Wockhardt today said Life Insurance Corporation (LIC) of India has sold 2.019 per cent stake held in the company for Rs 129 crore.

Overseas lenders, led by US-based hedge fund QVT, have proposed an alternative debt restructuring plan whereby they intend to buy a signifi...

The company’s debt-laden Swiss subsidiary is trying hard to strike a deal with offshore lenders even as the parent Wockhardt is involved in...

Foreign lenders led by US hedge fund QVT - that own overseas bonds worth $66 million in Wockhardt - have proposed a plan that would give th...

In what could be the biggest deal in the health care sector, leading hospital chain Fortis is finalising a pact for buying 10 of Wockhardt'...

Wockhardt is talking tough with banks that have unilaterally terminated their forex contracts with the company ahead of schedule.

Wockhardt is talking tough with banks that have unilaterally terminated their forex contracts with the company ahead of schedule.

Wockhardt Hospitals is in advanced talks to sell some of its key hospitals to Fortis Healthcare dropping an earlier plan to sell an equity ...

Debt-ridden Wockhardt Group expects to seal a deal to sell a minority stake in its healthcare chain, Wockhardt Hospitals, by May-end.

Wockhardt may have to hive off its biotech business into a separate company to clear the way for another company to pick up stake.

The Khorakiwala family, the promoters of pharmaceutical and biotechnology firm Wockhardt, pledged a 40% stake with financial institutions s...

Shares of Wockhardt Ltd today surged as much as 5 per cent on the Bombay Stock Exchange amid reports that the drug maker is looking for pot...

Drug major Wockhardt is looking for potential buyers for its French subsidiary Negma Laboratories to repay its debt to investors.

Domestic drug maker Wockhardt said on Wednesday it acquired US-based speciality drugs company Morton Grove Pharmaceuticals, which has annua...